Biosurgery Market Size, Share , Latest Trends, Key Players And Forecast To 2033

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Biosurgery Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $20.87 billion In 2028 At A CAGR Of 8.3%.

The biosurgery market size has grown strongly in recent years. It will grow from $14.01 billion in 2023 to $15.18 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to increasing surgical procedures, rise in chronic diseases, growing geriatric population, shift towards biodegradable product, regulatory changes and approvals..

The biosurgery market size is expected to see strong growth in the next few years. It will grow to $20.87 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to advancements in tissue engineering, rise in minimally invasive procedures, focus on regenerative medicine, shift towards biologics, aging population needs.. Major trends in the forecast period include growth in minimally invasive procedures, rise in cosmetic and plastic surgeries, focus on stem cell therapies, advancements in wound care, development of biodegradable products..

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=9380&type=smp

Biosurgery Market Major Segments
The biosurgery market covered in this report is segmented -

1) By Product: Bone-Graft Substitutes, Soft-Tissue Attachments, Hemostatic Agents, Surgical Sealants and Adhesives, Adhesion Barriers, Staple Line Reinforcement
2) By Source: Natural or Biologics Products, Synthetic Products
3) By Application: Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Gynecological Surgery, Other Applications
4) By End-User: Hospitals, Clinics, Other End-Users

Key Driver - Rising Prevalence Of Chronic Diseases Fuels Biosurgery Market Growth

The increase in the prevalence of chronic disease is expected to propel the growth of the biosurgery market going forward. Chronic disease refers to health problems that persist for a year or longer and necessitate continuing medical care, restricting everyday activities, or both. The main causes of death and disability in the US are chronic diseases such as diabetes, cancer, and heart disease. Biosurgery is used to eliminate dead tissue, lower the risk of infection, and speed up the healing process for chronic wounds. For instance, in March 2022, according to the Australian Bureau of Statistics, an Australia-based self-contained legal agency responsible for collecting and analyzing data as well as making evidence-based recommendations to federal, state, and territory governments, seventy-eight percent (78.6%) of Australians suffered from at least one chronic illness. 11.6 million individuals, or over half of the population, suffered from at least one chronic illness. Therefore, the increase in the prevalence of chronic disease is driving the growth of the biosurgery market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=9380&type=smp

Prominent Trend - Product Innovation To Revolutionize Wound Healing In The Biosurgery Market

Product innovations have emerged as the key trend gaining popularity in the biosurgery market. Major companies operating in the biosurgery market are developing product innovations to strengthen their position in the market. For instance, in April 2021, Aroa Biosurgery, a New Zealand-based manufacturer of medical and surgical products, launched Myriad Morcells, a Myriad Matrix morcellized (powder) configuration that easily adapts to improve interaction with uneven wound beds. It provides a burst of biologically significant ECM proteins in a format that fits the specifics of a wound in order to 'kick start' healing. A multi-layered extracellular matrix (ECM) graft with a high volume and surface area that has interstitial spaces that are quickly and easily accessible to cells is called Myriad Matrix. It makes use of the Aroa ECM bioscaffold technology, which incorporates crucial secondary chemicals and lingering vascular channels to assist the formation of new tissue.

Biosurgery Market Players
Major companies operating in the biosurgery market report are Baxter International Inc., B. Braun SE, Becton, Dickinson and Company, Hemostasis LLC, Integra LifeSciences Corporation, Johnson & Johnson Services Inc., CryoLife Inc., CSL Limited, Pfizer Inc., Zimmer Biomet Holdings Inc., Kuros Biosciences AG, Orthofix Medical Inc., Smiths & Nephew plc, Medtronic plc, Stryker Corp., Cyrolife Inc., Betatech Medical, Tissue Regenix Group plc, Aroa Biosurgery Ltd., Anika Therapeutics Inc., Arthrex Inc., B Braun Surgical SA, Biom'Up SA, Boston Scientific Corporation, Coloplast Corp., Cook Medical Inc., Endo International plc, Genzyme Corporation, Takeda Pharmaceutical Company Limited, Cerus Corporation .

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/biosurgery-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the biosurgery market in 2023. Asia-Pacific is expected to be the fastest-growing region in the biosurgery market report during the forecast period. The regions covered in the biosurgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Biosurgery Market Report Structure
3. Biosurgery Market Trends And Strategies
4. Biosurgery Market - Macro Economic Scenario
5. Biosurgery Market Size And Growth
…..
27. Biosurgery Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.